On-Prem

Systems

IBM and GlobalFoundries settle multibillion-dollar trade secret and contract lawsuits

Clears way for 'new opportunities' for collab, say pair


IBM and semiconductor maker GlobalFoundries have settled all of their litigation against each other, including breach of contract, patent, and trade secret suits, the pair say.

The details of the settlement are confidential. All that both companies were prepared to say in yesterday's statements was that the deal they'd agreed would resolve "all litigation matters, inclusive of breach of contract, trade secrets, and intellectual property claims between the two companies." They added that the settlement would allow the companies to "explore new opportunities for collaboration in areas of mutual interest."

IBM: Hey Joe, we make chips, too. How about some of 'em subsidies?

READ MORE

The disputes and litigation between IBM and GlobalFoundries, formerly AMD's chipmaking unit which it spun out in 2009, were complex and spanned both state and federal courts.

The first main shot was fired by IBM in 2021, in a New York state court, over chip production (or non-production). The pair had signed a $1.5 billion deal in late 2014 where IBM transferred its semiconductor manufacturing business to GlobalFoundries. GF was supposed to take over the delivery of 14 nanometer technologies for IBM Power and z processors and deliver 10nm and smaller wafer-etching techniques as part of a ten-year agreement.

As our sister site The Next Platform mentioned at the time, there had been delays in getting 14nm chips out of the fabs. A spiking of the 10nm and then later the 7nm process, in August 2018, at least in Big Blue's estimation, had left it "without a server roadmap, essentially." IBM asked the court for $2.5 billion in damages, which GF contested in its own complaint [PDF] was a baseless claim. GF claimed at the time that not only had it "fulfilled its contractual obligations to IBM" but that Big Blue's switch to Samsung as a supplier of 7nm processor chips for datacenters had actually saved IBM money and cut delivery times (though the judge wasn't convinced by the arguments).

The second key lawsuit, filed by GlobalFoundries in 2023 in a New York federal court, involved partnerships announced between Big Blue and Intel and Japan's Rapidus in 2021 and 2022 respectively. In the 2023 suit, the semiconductor maker accused IBM of unlawfully disclosing its confidential trade secrets and IP to its partners. It also alleged [PDF] in the complaint that IBM had been performing a "systemic poaching of GF's most qualified semiconductor manufacturing engineers in order to generate even more licensing revenue by enabling other companies with GF IP."

IBM's mainframe bubble bursts and growth stalls

READ MORE

In their joint statement, the companies also expressed that the confidential settlement created "satisfaction with the outcome" from both parties. Some might suggest it makes sense to be cooperative and collaborative, especially as a potential outcome of the injunction GlobalFoundries had been asking for in the 2023 complaint may well have derailed Intel and Rapidus's roadmaps, as The Reg previously mentioned here. This is meaningful to IBM, which said last month it was "moving closer to scaling out 2nm chip production" in its partnership with Rapidus. GF had originally claimed in the now settled [PDF] federal lawsuit that when IBM planned to share the "technology underlying the '2nm node chip'" with Rapidus that this had allegedly included "GF-Controlled Trade Secrets that were developed by GF and IBM."

IBM and Rapidus presented their research on strategies for selective nanosheet layer reduction – which should help them more consistently construct chips with a 2nm process – at the IEEE International Electron Devices Meeting in San Francisco in December.

GlobalFoundries, fined $500,000 last year for sanctions violations involving China, was awarded up to $1.5 billion in November last year under the US government's CHIPS and Science Act.

America's Commerce Department claimed GlobalFoundries was one of "only four companies outside of China" that it considered could provide foundry capabilities for current and mature process nodes on a necessary scale for the act's national goals, and is the only one of these headquartered in the United States. ®

Send us news
Post a comment

How the OS/2 flop went on to shape modern software

Even Microsoft's lead architect misunderstood the failure

China to probe US chip subsidies as export curbs rattle allies

Beijing investigating claims of unfair competition in mature semiconductors

IBM swoops in to rescue UK Emergency Services Network after Motorola shown the door

With a near half-billion-pound price hike bringing contract value to £1.4B

TSMC plans to have 1.6nm chips in 'volume production' by 2026

You've got to spend money – like $36 billion+ – to make, er, AI chips

US adds Chinese RISC-V player that TSMC suspected of helping build Huawei GPUs to risky company register

Sophgo scores a place on Entity List, Indian nuclear boffins taken off

Biden said to weigh global limits on AI exports in 11th-hour trade war blitz

China faces outright ban while others vie for Uncle Sam's favor

MediaTek rings in the new year with a parade of chipset vulns

Manufacturers should have had ample time to apply the fixes

US logic in question, but perhaps American memory can still prevail

With Intel's foundry future in doubt, Micron takes center stage in US Chips Act push

UK watchdog launches inquiry into IBM's HashiCorp acquisition

To the surprise of no one, a multi-billion dollar deal comes under CMA scrutiny

Jury spares Qualcomm's AI PC ambitions, but Arm eyes a retrial

The victory may be short lived as the chip designer gears up for second round

Intel sued again over struggling foundry business

Derivatives claim seeks damages from execs and board members

Jury trial kicks off Arm's wrestling match with Qualcomm

The Nuvia buyer's alleged violations of license terms expected to last through Friday